Evidence map›Paper›PMID 34352700›Full record

ArticleLeukemia research2021

Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: First results from a patient survey by the German Study Group for MPN.

Kim Kricheldorf, Konstanze Döhner, Frank Stegelmann, Philipp J Jost, Fabian Lang, Markus Radsak, Richard Hansen, Vera Heuer, Rainer Röhrig, Tim H Brümmendorf and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kim KricheldorfDepartment of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Germany. Electronic address: kkricheldorf@ukaachen.de.
Konstanze DöhnerDepartment of Internal Medicine III, University Hospital of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. Electronic address: konstanze.doehner@uniklinik-ulm.de.
Frank StegelmannDepartment of Internal Medicine III, University Hospital of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. Electronic address: frank.stegelmann@uniklinik-ulm.de.
Philipp J JostMedical Department III, School of Medicine, Technical University Munich, Ismaninger Str. 22, 81675, München, Germany; Clinical Department of Oncology, Medical University Graz, Auenbruggerplatz 15, 8036, Graz, Austria. Electronic address: philipp.jost@tum.de.
Fabian LangDepartment of Medicine, Hematology/Oncology, Goethe-University, Theodor-Stern-Kai 7, 60590 Frankfurt a. Main, Germany. Electronic address: Fabian.Lang@kgu.de.
Markus RadsakIIIrd Department of Internal Medicine, University Johannes Gutenberg-Universität, Mainz, LangenbecksTraße 1, 55131, Mainz, Germany. Electronic address: markus.radsak@unimedizin-mainz.de.
Richard HansenOncological Practice Dres. Hansen & Reeb, Schneiderstraße 12, 67655, Kaiserslautern, Germany. Electronic address: Richard.hansen@pfalz-onko.de.
Vera HeuerSt. Anna Hospital Herne, Hospitalstraße, 19 44649, Herne, Germany. Electronic address: Vera.Heuer@elisabethgruppe.de.
Rainer RöhrigInstitute of Medical Informatics, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany. Electronic address: rroehrig@ukaachen.de.
Tim H BrümmendorfDepartment of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Germany. Electronic address: tbruemmendorf@ukaachen.de.
Steffen KoschmiederDepartment of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Germany. Electronic address: skoschmieder@ukaachen.de.
Susanne IsfortDepartment of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Pauwelsstrasse 30, 52074, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Germany. Electronic address: sisfort@ukaachen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedAged, 80 and overCOVID-19FemaleFollow-Up StudiesGermanyHumansMaleMiddle AgedMyeloproliferative DisordersPrognosisSARS-CoV-2Surveys and QuestionnairesTelemedicine

Identifiers

PMID34352700
PMCPMC8205549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.